2024 Health and Welfare Plan Challenges for Plan Sponsors, Administrators, and Counsel
Impact of New Fiduciary Rule on Plans and HSAs, Health Plan Litigation, Drug Pricing, Transparency Issues, Disclosures, Use of PEOs
Recording of a 90-minute premium CLE video webinar with Q&A
This CLE webinar will provide guidance on all of the above issues. The panel will discuss the impact of the new fiduciary rule for health plans and HSAs, litigation issues, including potential new fiduciary duty claims, prescription drug pricing, transparency issues, litigation updates, and other key issues for health and welfare plan sponsors, administrators, and their counsel.
Outline
- Evaluating legislative changes addressing prescription drug pricing, transparency, and mandated compensation disclosures
- Examining recent health plan litigation and steps to minimize claims and liability
- RevDOL audit priorities and how to address in advance
- Review proposed changes to the Mental Health Parity and Addiction Equity Act, and potential litigation issues arising from the same
- Key issues stemming from the new fiduciary rule for health plan sponsors and administrators
Benefits
The panel will discuss these and other key issues:
- Update on new legislation and regulation regarding prescription drug pricing, transparency, mandated disclosures, and access to care
- Examining recent health plan litigation and next steps to minimize claims and liability
- Examining DOL priorities in audits and how to address these issues
- Proposed changes to DOL regulations governing the Mental Health Parity and Addiction Equity Act, and potential litigation issues arising from the same
- Key issues stemming from the new fiduciary rule for health plan sponsors and administrators
Faculty
Andrew Holly
Partner
Dorsey & Whitney
Mr. Holly serves as co-chair of Dorsey’s ERISA Litigation Practice Group. He has 20 years' experience... | Read More
Mr. Holly serves as co-chair of Dorsey’s ERISA Litigation Practice Group. He has 20 years' experience representing fiduciaries, sponsors, and insurers in ERISA litigation matters. For the last three years, he has been ranked by Chambers as one of the top ERISA litigators in the nation.
Close